GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » Institutional Ownership

Codon AG (HAM:CNW) Institutional Ownership : 0.05% (As of May. 26, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Codon AG Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Codon AG's institutional ownership is 0.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Codon AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Codon AG's Float Percentage Of Total Shares Outstanding is 0.00%.

Codon AG Institutional Ownership Historical Data

The historical data trend for Codon AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG Institutional Ownership Chart

Codon AG Historical Data

The historical data trend for Codon AG can be seen below:

2022-05-31 2022-07-31 2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31
Institutional Ownership 1.34 0.53 0.53 0.48 0.48 0.12 0.12 0.12 0.12 0.05

Codon AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Codon AG (HAM:CNW) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » Institutional Ownership
Comparable Companies
XTER:T3T1 XTER:PDA XTER:UMDK FRA:TIS STU:QS6A OCSE:NOVO B VRTX REGN ASX:CSL SGEN MRNA XKRX:207940 XBRU:ARGX BNTX HKSE:02269 OCSE:GMAB ALNY BGNE XBRU:UCB BMRN
Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Website
http://www.codon.de
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.